Reprogramming cancer cells into immune defenders
By reprogramming tumor cells to become the body's defenders, Filipe Pereira and his colleagues hope to improve current cancer treatments.
Dec 22, 2022
0
5
By reprogramming tumor cells to become the body's defenders, Filipe Pereira and his colleagues hope to improve current cancer treatments.
Dec 22, 2022
0
5
Researchers have been experimenting with different ways to deliver genes to the brain to treat central nervous system diseases and tumors. One of the obstacles, however, is the ability to penetrate the blood-brain barrier ...
Oct 18, 2022
0
68
Gene therapies aim to cure severe, barely treatable monogentic diseases caused by a defect in a single gene. Medical hopes are correspondingly high. Some gene therapies have already been approved in Europe—for example, ...
Aug 2, 2022
0
15
A 28-patient phase 1 gene therapy clinical trial for the degenerative retinal disease Leber hereditary optic neuropathy (LHON) found no significant safety concerns; however, treatment failed to improve or slow vision loss, ...
Jun 2, 2022
0
2
The first three coronavirus vaccines earned Emergency Use Authorization more than a year ago. To date, no other vaccines have been put into use in the U.S—but that will soon change. More than 40 vaccines are undergoing ...
May 5, 2022
0
119
An international team of scientists believe they may have found a molecular mechanism behind the extremely rare blood clots linked to adenovirus COVID-19 vaccines.
Dec 2, 2021
1
425
How would you go about solving a puzzle if you didn't know what pieces to use, how many you would need, how it was supposed to look when you were done or what possible function it would serve?
Oct 18, 2021
0
2
As Australia strives to reach its national COVID vaccination targets, there's unprecedented focus on the biological effects of vaccines.
Oct 8, 2021
0
10
Neurological disorders such as Parkinson's disease and epilepsy have had some treatment success using deep brain stimulation devices, but those require invasive and expensive surgical implantation. Now engineers funded by ...
Sep 23, 2021
0
2
The NHS has very recently approved a new cholesterol-lowering jab which will be offered to 300,000 people over the next three years.
Sep 10, 2021
0
3